News & Perspective

(CIDRAP News) – An annual report released yesterday by the US Centers for Disease Control and Prevention (CDC) profiles a wide range of CDC influenza-related projects around the world, from flu surveillance in Indonesia to vaccine effectiveness studies in El Salvador and epidemiology training in Ghana.

In the wake of a newspaper investigation that questioned the value of the federal BioWatch program for detecting dangerous airborne pathogens, some public health officials familiar with the program acknowledge that it's far from perfect, but they say it's not time to scrap it.

(CIDRAP News) – The federal agency tasked with shoring up the nation's preparedness against a host of public health emergencies released a plan yesterday to help it and other partners focus and coordinate steps to meet national preparedness objectives.

(CIDRAP News) – International experts say that, while experiments on H5N1 avian flu transmission in mammals are important, publishing full details of such "dual-use" studies likely will not speed up the vaccine response in a pandemic, according to a news report and editorial in Nature today.

(CIDRAP News) – Though the United States has improved its ability to respond to small-scale bioterror events, it is still unprepared to protect its citizens against large attacks, according to the latest assessment today from a bipartisan commission established to advise Congress.

(CIDRAP News) – A Senate committee began work on reauthorizing the Pandemic and All-Hazards Preparedness Act (PAHPA) yesterday by calling federal and public health officials before them to testify about gaps and what steps are needed to better prepare the nation against flu and bioterror threats.

(CIDRAP News) – A report from the National Research Council (NRC) calls for some changes in a US Army immunization program for lab researchers who work with dangerous pathogens, saying the vaccines need to be made more accessible to civilian scientists.

(CIDRAP News) – A workshop summary released today by the Institute of Medicine (IOM) offers a wide range of observations and suggestions about what worked well and not so well during the pandemic H1N1 influenza vaccination campaign—a complex, months-long operation with a cast of thousands.